Back |
home / stock / dmac / dmac message board
Subject | By | Source | When |
---|---|---|---|
John Mauldins Biotech company -- DiaMedica (TSXV:DMA; OTCQB:$DMCAF) | Regis999 | investorshub | 04/16/2018 6:06:52 PM |
Emylers: DMCAF Financials 07/16/2014 09:48:28 Diamedica, Inc. Period Ending Total Revenue Cost of Re | Emylers | investorshangout | 07/16/2014 2:48:25 PM |
Stock Tracker: Latest Diamedica Inc (DMCAF) Headlines Aon Benfield Exec: China Moving Towards Second | Stock_Tracker | investorshangout | 03/09/2014 7:03:21 PM |
chartguy89: DMCAF 0.832 Stock Charts $DMCAF 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 1:57:30 AM |
chartguy89: DMCAF Stock Charts Last: -0.031 Tuesday, February 25, 2014 at 10:10:33 AM $DMCAF | chartguy89 | investorshangout | 02/25/2014 3:10:44 PM |
News, Short Squeeze, Breakout and More Instantly...
DiaMedica Therapeutics Inc. Company Name:
DMAC Stock Symbol:
NASDAQ Market:
DiaMedica Therapeutics Inc. Website:
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its previously announced $11.8 million private placement to accredited investors. The Company sold approximatel...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 73.0% to $0.4585 on volume of 640,087,036 shares Ocean Power Technologies Inc. (OPTT) rose 34.9% to $0.1812 on volume of 396,326,565 shares NVIDIA Corporation (NVDA) rose 0.2% to $1...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced that it has entered into definitive agreements to sell its common shares in a private placement with accredited investors. Th...